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Abstract
The study of amphibian embryogenesis has provided important insight into the mechanisms of
vertebrate development. The frog Xenopus laevis has been an important model of vertebrate cell
biology and development for many decades. Genetic studies in this organism are not practical
because of the tetraploid nature of the genome and the long generation time of this species.
Recently, a closely related frog, namely Xenopus tropicalis, has been proposed as an alternative
system; it shares all of the physical characteristics that make X. laevis a useful model but has the
advantage of a diploid genome and short generation time. The rapid accumulation of genetic
resources for this animal and the success of pilot mutagenesis screens have helped propel this
model system forward. Transposable elements will provide invaluable tools for manipulating the
frog genome. These integration systems are ideally suited to transgenesis and insertional
mutagenesis strategies in the frog. The high fecundity of the frog combined with the ability to
remobilize transposon transgenes integrated into frog genome will allow large-scale insertional
mutagenesis screens to be performed in laboratories with modest husbandry capacities.
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Introduction
The frog Xenopus laevis has been used to study early stages
of vertebrate development for more than 50 years and
continues to be an important model system. The frog lays
abundant eggs that are large, develop synchronously, and are
easy to manipulate. Genetic manipulation of this tractable
model system would further enhance the use of the frog in
developmental studies. Two features of X. laevis that have
hindered genetic studies are the long generation time (1 to
2 years) and the tetraploid genome of this species. The closely
related frog Xenopus tropicalis shares all the features of X.
laevis that make this system useful for embryonic
manipulation but it develops more rapidly (sexual maturity is
reached in 5 to 9 months) and has a diploid genome. 
Transposons have widely been used in plant and inverte-
brate model species to integrate foreign DNA into the host
genome. In recent years, these powerful genetic tools have
been used in higher vertebrates for transgenesis, insertional
mutagenesis, and gene therapy applications. The ‘cut-and-
paste’ DNA transposons are particularly useful for these
applications. The Sleeping Beauty transposase system was
developed in the late 1990s and has been widely used in a
range of vertebrate systems. A common ancestor cloning
strategy was used to engineer the active transposase enzyme
from an inactive form found in teleosts. A genetic toolbox of
‘cut-and-paste’ DNA transposable elements is now available
for use in vertebrates and includes Tol2 and piggyBac.
Here, we review the application of transposable elements to
modification of the frog genome. Transposon vectors can be
used in the frog for transgenesis and for insertional
mutagenesis where enhancer trap and gene trap constructs
are used to identify genomic loci involved in developmental
processes. Once integrated into the frog genome, the ‘cut-
and-paste’ DNA transposons are targets for remobilization
by re-expression of the appropriate transposase enzyme.
Transgenic frogs that express the enzyme in the germline
can be bred with animals harboring a transposon substrate
to generate double transgenic lines where remobilization
will occur in the germline in subsequent generations. The
high fecundity of the frog can be exploited in these remobili-zation strategies because each outcross of X. tropicalis can
generate more than 2,000 offspring.
Xenopus as a developmental genetic model
For more than a century amphibian species have been used
as model organisms for the study of vertebrate development
[1]. Several features of amphibian embryonic life make these
animals useful as models for studying early developmental
events. First, the embryos are fertilized outside the mother
and are thus accessible for study at the earliest stages of
development. Second, the eggs are large and easy to
manipulate under low power microscopy. Third, many
amphibian species lay vast numbers of eggs, providing
adequate numbers for study. Fourth, each cell of the
developing frog embryo contains yolk platelets that provide
nutrition during prefeeding stages of embryonic life. This
allows explanted cells to survive in simple salt solutions for
several days and enables study of isolated embryonic tissues
and cells. Fifth, Xenopus embryos are optically transparent
for most of their embryonic life, which allows direct visualiza-
tion of developing organ systems. Finally, amphibians are
tetrapods and their body plan is similar to that of mammals,
providing important advantages over other model systems for
study of organs that are only present in higher vertebrates.
The South African clawed frog X. laevis has been a favored
model for developmental biologists for many decades. The
entire life cycle of these animals is aquatic, which simplifies
husbandry because they can be maintained in simple
aquaria and do not need a terrestrial habitat. Unlike many
other amphibian species that require seasonal cues for
initiation of egg laying, Xenopus spp. can be induced to lay
eggs throughout the year by simple hormone injections. The
embryos are large and are laid in vast numbers. A single
female can lay in excess of 1,000 eggs per ovulation and can
be induced to lay eggs several times a year. The large egg size
and rapid development allows for simple manipulation of
gene expression by microinjection techniques. Ectopic
expression can be achieved by injection of synthetic mRNAs
to achieve early expression of proteins. The timing of protein
expression can be delayed by injecting plasmid constructs in
which a promoter drives expression of the introduced gene,
thus delaying expression until after the mid-blastula
transition when zygotic transcription begins. Expression of
endogenous proteins can be manipulated using either
dominant-negative constructs or by injecting anti-sense
morpholino oligonucleotides to achieve a ‘knock-down’ of
the target protein.
The large and rapidly dividing embryos are ideal for embry-
onic manipulations such as explant and transplantation
techniques. Explanted primitive ectoderm (commonly called
the animal cap assay) provides a source of pluripotent cells
that can be used in a variety of tissue induction assays. The
explanted animal caps can be induced with growth factors to
differentiate into all cell types found in the embryo. For
example, addition of the transforming growth factor-β
family member activin can lead to a dose dependent
differentiation of the nascent ectoderm to mesodermal and,
at high doses, endodermal cell types [2].
Although X. laevis is an excellent developmental model and
has been used extensively for ‘classical’ embryologic mani-
pulations, genetic studies in X. laevis are not considered
feasible. This is because of the long generation time of this
species (1 to 2 years) and its tetraploid genome. A genome
wide duplication event occurred in X. laevis approximately
10 to 40 million years ago [1]. As such, this species maintains
four copies of each gene. The combination of these physical
attributes makes this species an unsuitable candidate for a
genetic model. The advantages of combining the excellent
features of the frog for embryonic manipulations and the
power of modern molecular genetics has led investigators to
identify another candidate frog for genetic analyses. The
West African clawed frog, X. tropicalis, is a close relative of
X. laevis and is a true diploid. X. tropicalis shares all the
features of X. laevis that makes this species an excellent
embryologic model, but it has the advantages of shorter
generation time and diploid genome [3].
X. tropicalis is smaller than X. laevis, although it is a
genetically similar organism, and it has multiple advantages
over X. laevis for genetic studies. First and foremost, genetic
studies have revealed X. tropicalis to be a true diploid,
containing ten pairs of chromosomes as compared with 18
pairs for X. laevis. X. tropicalis adults also reach breeding
age faster than do X. laevis adults (males 4 to 6 months and
females 6 to 8 months for X. tropicalis versus about 1 year
for X. laevis) [4]. Adult female X. tropicalis produce smaller
eggs (1.0 to 1.3 mm for X. laevis versus 0.7 to 0.8 mm X.
tropicalis) in numbers similar to those with X. laevis (1,000
to 3,000 per ovulation), and the eggs can be manipulated in
the same manner as X. laevis oocytes, including micro-
injection. In essence, all experiments performed in X. laevis
can be performed in X. tropicalis.
Because both frog species are genetically similar, genes and
their regulatory elements, such as enhancers and promoters,
can be cross-utilized in both species. Full-length cDNA
clones from X. laevis and X. tropicalis have been analyzed
for comparison between species as well as with higher
vertebrates [5]. In addition to the experimental data that can
be generated using X. tropicalis, genetic resources are
accumulating [6,7]. Expressed sequence tags (ESTs) have
been generated from multiple tissues and developmental
stages for both X. laevis and  X. tropicalis and are freely
accessible in gene databases such as Genbank. X. tropicalis
now ranks sixth for the number of ESTs per organism
deposited into Genbank as of August 2007 [8]. In
conjunction with establishment of cDNA libraries and ESTs,
the X. tropicalis genome is being sequenced and annotated
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available to the entire Xenopus community. Microarray
chips prepared in combination with Affymetrix and the
Xenopus community have provided a valuable resource to
allow rapid analysis of thousands of genes under various
experimental conditions. The rapid pace at which these
valuable genomic tools have been developed establishes the
potential ongoing and future role of X. tropicalis in genetic
studies.
Several features of the natural history of the frog make this
tetrapod an attractive model for genetic analyses. The high
fecundity of the frog results in many offspring from each
cross.  X. tropicalis colonies are easy to maintain in the
laboratory, and the animals will live for approximately two
decades in captivity. The long life-span has obvious
advantages in maintaining transgenic and mutant founder
lines for many years, with the ability to out-cross and back-
cross these animals over multiple generations. The ability to
generate fertile animals by gynogenesis allows rapid
generation of homozygous lines. Haploid X. tropicalis
embryos can be generated by fertilizing eggs with UV treated
sperm. The irradiation of the male gametes results in cross-
linking of the genetic material and blocks the contribution of
the male DNA to the fertilized egg. The resulting eggs will
develop for several days as haploids with only the maternal
chromosomes. Gynogenetic diploids can be rescued from
haploid embryos by several methods, such as hyperbaric
pressure or cold shock, which prevent either exclusion of the
polar body or disruption of the mitotic spindle during the
first cleavage event [3]. The result of these physical
treatments is that the embryo will contain two copies of the
maternal chromosomes and is rescued from the early demise
that haploid embryos are fated to. The ability to generate
gynogenetic diploid animals in large numbers is useful for
mapping studies and for decreasing the number of genera-
tions (and thus yielding savings in terms of valuable time
and space) required for developing homozygous lines. Another
feature of the frog that is useful for genetic studies is the
ability to sex bias populations of tadpoles to generate either
female or male adults. For example, to skew a population of
tadpoles toward adult females, estrogens are added to the
water before the developmental stage when the germ cells
are migrating to the gonad. Feminization of the gonad with
estrogen results in the developing frog becoming a female.
The ability to separate gonadic sex from genetic sex provides
another useful tool for developmental genetic studies.
With the diploid X. tropicalis as a new genetic model, a
number of laboratories have undertaken forward and reverse
genetic mutant screens. Induced mutations can identify
critical genes involved in early development. Treatment of
mature sperm with N-ethyl-N-nitrosourea (ENU), a potent
alkylating mutagen, has successfully been applied in
zebrafish for small [9] and large genetic screens [10]. With
the success of the ENU mutagenesis screen in zebrafish and
the benefits of these mutations for the study of develop-
mental pathways, several X. tropicalis laboratories have
undertaken ENU mutagenesis screens. For example, the
laboratories of Zimmerman and Stemple [11] recently
conducted a pilot ENU mutagenesis screen using X.
tropicalis. A number of mutant phenotypes was identified,
including those of the nervous, hematopoietic, and digestive
systems. Although ENU is a powerful tool for obtaining
mutants, identification of the genetic lesion induced by ENU
is potentially time consuming and often requires extensive
positional cloning strategies to uncover the affected gene.
In addition to mutations that can be generated by chemical
mutagenesis protocols, naturally occurring mutants have
been identified in inbred lines of X. tropicalis. The Harland
group at  the University of California-Berkeley [4] have
described three naturally occurring embryonic lethal recessive
mutations (grinch, curly, and bubblehead) by inbreeding a
Nigerian strain of X. tropicalis.  Grinch mutants exhibit
pericardial edema at the onset of heartbeat (about stage 35)
and die by stage 48 of development. Curly mutants have a
characteristic curved tail and die at around stage 40. The
bubblehead mutation leads to smaller body size, craniofacial
defects, and edema, leading to death of the embryos at
around stage 40. In addition, carrier adults for each
mutation can be crossed with other carriers (for example,
curly ×  grinch) and compound mutants can be obtained
exhibiting characteristics of each natural mutation identified
[4]. A gynogenetic screen of wild caught animals performed
in the Grainger laboratory at the University of Virginia [12]
identified recessive mutant alleles that resulted in defined
phenotypes when forced to homozygousity. In the latter
study, 42 mutant phenotypes were obtained and include
puffy eye, directionless, and heartbreaker. These mutations
are excellent models in which to study gene function in vivo.
However, as with ENU screens, identification of the gene
responsible for the mutant phenotype is a laborious process
because these mutations may be the result of complex
genetic lesions. Nonetheless, these mutants provide an ideal
starting point for the establishment of X. tropicalis in
genomic studies.
Trangenesis in Xenopus
Although the frog has been an excellent model in which to
study early aspects of vertebrate development, the ability to
create transgenic animals has been lacking. Within the past
20 years, however, molecular techniques have been
developed to create transgenic Xenopus lines. Germline
transgenesis in X. laevis was first described by Etkin and
Pearman [13] and used a simple microinjection approach to
introduce linear plasmid DNA into the fertilized egg.
Random integration of the transgene at early cleavage stages
resulted in transmission of the chloramphenicol acyl trans-
ferase reporter through the germline. Although this
technology has proved effective for generating transgenic
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method has not been widely used in X. laevis, probably
because of the highly mosaic integration of the transgene in
founder lines and the long generation time for this organism.
The mosaicism of the founders precludes analysis of
transgene activity in the founder animals, and the lengthy
generation time in X. laevis results in a 1 to 2 year delay in
analysis of the F1 progeny. In addition, the frequency of
germline transgenic animals produced by this method is low
(Johnson Hamlet MR, Mead PE, unpublished data).
Another method for generating transgenic Xenopus was
described by Kroll and Amaya [14] and used restriction
endonuclease-mediated integration (REMI). In this
approach, linearized plasmid DNA is mixed with sperm
nuclei in the presence of the restriction enzyme used to
linearize the transgenic construct. Digestion of the sperm
DNA causes double strand breaks, enabling integration of
the linearized plasmid DNA into the sperm haploid genome.
The treated sperm nuclei are then injected into mature
oocytes. The injection process activates the egg, the cellular
machinery repairs the damaged sperm DNA, and normal
development proceeds. One advantage of REMI is the
potential to analyze embryos at the founder (P0) stage,
whereas other transgenesis techniques develop chimeric P0
animals [14]. REMI results in integration of the transgene in
the sperm nuclei before fertilization and the resulting
embryo is not chimeric. Transgenic X. tropicalis [15] have
successfully been created using a modified REMI procedure
using the gamma-crystallin promoter to drive green
fluorescent protein (GFP) expression in the developing lens
of  X. tropicalis. Modifications to the REMI protocol have
been developed by various laboratories and have led to
higher transgenesis efficiencies [16]. However, several
problems arise through the use of the REMI transgenesis
techniques. High quality eggs and oocyte extracts for sperm
nuclei incubation are required for efficient transgenesis, but
they can be difficult to obtain, resulting in low numbers of
healthy founders [17]. Furthermore, the presence of the
restriction endonuclease and the physical manipulation of
the sperm nuclei can result in DNA damage and cause
complex genetic lesions in the founder animals.
A modification to the standard linear DNA injection strategy
has led to a new methodology for creating transgenic
animals. Linear DNA fragments with meganuclease I-SceI
restriction endonuclease sites are injected into the fertilized
egg, together with a small amount of the enzyme. The I-SceI
meganuclease enzyme, a Saccharomyces cerevisiae endo-
nuclease [18], has an 18 base pair recognition sequence and
as such will have very few, if any, target sites in even
complex vertebrate genomes. I-SceI restriction sites are
engineered into the plasmid vector containing the transgene
and the linearized vector is injected into fertilized eggs
together with the I-SceI enzyme. In standard transgenesis
protocols, such as the one described above [13], linearized
DNA injected into the fertilized egg forms large concatamers
due to the activity of cellular DNA repair systems. The
ligation of the transgene into large concatamers is thought to
decrease the efficiency of integration of the transgene into
the target genome. The presence of the I-SceI meganuclease
in the injected sample results in cleavage of the nascent
concatamers, thus increasing the pool of linear, single copy
transgene substrates for integration into the host DNA. The
genomic DNA of the fertilized egg is spared from digestion
by the meganuclease because the 18 base pair recognition
sequence will occur very infrequently, if at all, in the frog
genome. The I-SceI system was recently shown to be effective
for generating transgenic X. tropicalis [17]. Reporter assays
in  X. tropicalis using the Pax6 promoter driving GFP
flanked by two I-SceI  sites co-injected with meganuclease
yields embryos with correct temporal expression of GFP in
the developing eyes and later in the spinal cord and brain
[17]. The rate of trangenesis (about 30%) using mega-
nuclease is higher than that with REMI (about 2% to 5%)
using the same promoter construct [17]. In addition to
higher rates of transgenesis, efficient germline transmission
of  Pax6 promoter constructs was achieved with the
meganuclease system. The I-SceI meganuclease is therefore
another tool that the Xenopus community can utilize to
create multigenerational transgenic lines.
To achieve efficient and reliable production of transgenic
animals, we believe that transposable elements provide the
ideal tool with which to create transgenic frogs for large scale
genomic studies. Transposons offer several advantages for
transgenesis and insertional mutagenesis. A number of
laboratories have effectively used transposon based systems,
such as Sleeping Beauty,  Tol2, and phiC31 integrase, to
create stable transgenic Xenopus. Other reviews in this
supplement describe in detail these transposon systems; we
briefly discuss the role played by each of these systems in
relation to Xenopus and discuss the future use of these
powerful genomic systems in X. tropicalis.
The bacteriophage phiC31 is a member of the resolvase/
invertase family of recombinases that inserts foreign DNA
into specific sites within the genome [19]. The phiC31
recombinase requires two minimal DNA integration sites,
namely attB and attP. Upon recombination, two novel sites
are created, attL and attR, which prevent remobilization of
the inserted DNA fragment in the presence of integrase. In
phiC31 susceptible bacteria, a phage attachment site (attP) is
present in the genome and is a target for the integrase
enzyme. In vertebrates the precise attP sequence is not
present in the genome. Recent studies have demonstrated
that there is a limited number of sequence motifs similar to
attP sites, and these functional ‘pseudo’ attP sites allow site-
specific integration of phiC31 to occur [20]. In addition to
recognizing site-specific DNA elements and unidirectional
integration of DNA, phiC31 integrase requires no host co-
factors for integration to occur and is therefore likely to
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within its genome. Thus, it is a highly attractive system for
the insertion of novel DNA elements for gene therapy as well
as the creation of transgenic animals [21]. The integrase
phiC31 has been studied in mammalian cultured cell lines
[21,22] and in vivo animal models [22]. In the frog, Allen
and Weeks [23] have shown in X. laevis that  phiC31 can
effectively integrate a cytomegalovirus promoter driven GFP
reporter plasmid into the genome. GFP was first seen at the
onset of neurulation (stage 14) and was monitored for 8 days
after fertilization. Integration rates for the integrase ranged
from 4% to 40%, depending on the amount of integrase
mRNA used for injection [23]. Although the phiC31 inte-
grase results in X. laevis are promising, further analysis is
needed with this transposon system in both species of frog
(X. laevis and X. tropicalis). For example, germline trans-
mission of the transgenes has not been shown using the
phiC31 system in frogs.
Transposons are autonomous mobile DNA elements found
in the genome of many metazoans with no identifiable
function. For the developmental biologist, these mobile
elements provide powerful genomic tools. The first active
vertebrate transposase to be developed was Sleeping Beauty
(SB), a member of the Tc1/mariner superfamily of trans-
posable elements. Activity of this ancient inactive transposi-
tion system was restored using reverse engineering. Trans-
poson sequences from related fish species were compared to
predict the common ancestral sequence of the active
transposase [24,25]. SB has been used with success in
multiple vertebrate model organisms, including mouse
[26-31] and zebrafish [32,33]. SB integrates its cognate
transposon through direct/indirect repeats integrated at
random TA dinucleotides in the targeted genome. There is
no evidence for sequence site specificity for SB in the
genome [28]. It is highly efficient, integrating from one to
multiple copies of the transposon into the genome of
interest. The random integration of the transposon provides
an excellent tool for generating novel insertion events for
gene and enhancer trap screens. Recently, Sinzelle and
coworkers [34] showed, employing a simple coinjection
procedure in X. laevis, that the SB transposase can
effectively integrate foreign DNA into the frog genome. They
demonstrated DNA reporter integration and transmission in
the germline to offspring and that by the F2 generation
Mendelian ratios are achieved. Interestingly, they demon-
strate that although the SB enzyme is required for
integration of the transposon sequences into the frog
genome, the integration events are noncanonical and result
in inclusion of vector sequences. We have used the SB
system in our laboratory and have observed similar non-
canonical transposition events in both X. laevis and
X. tropicalis [35] (Yergeau DA, Mead PE, unpublished data).
Despite the noncanonical nature of the SB transposition
reaction in Xenopus, this system offers an efficient method
for generating transgenic lines.
The autonomous Tol2 transposable element, a member of
the hAT (hobo of  Drosophila,  Ac of maize, and Tam3 of
snapdragon) family of transposons, was identified as the
genetic lesion in a naturally occurring albino mutation in the
teleost medaka (Oryzias latipes) [36]. The Tol2 element was
the first functional DNA-based transposon system to be
identified in vertebrates. The Tol2  transposon encodes a
functional transposase enzyme that can catalyze the
mobilization of the entire transposon. Genetic manipulation
of the Tol2 element was used to derive a non-autonomous
system for use as a genetic tool in vertebrate cell lines and in
transgenesis [37,38]. The enzymatic activity of the natural
element was deleted from the transposon so that self-
mobilization was no longer possible. Reporter genes were
cloned into the transposon element and transposase activity
was supplied in trans  by co-transfection with the cloned
transposase sequence. Several laboratories have used the
Tol2 non-autonomous element in zebrafish for enhancer
trap [39,40] and gene trap screens [41]. The Kawakami
group [42] first demonstrated that Tol2 transposase could
excise a Tol2 transposon from a plasmid vector in frog
embryos with high efficiency. They note there are differences
in the excision pattern between frog and zebrafish suggest-
ing species-specific host factor interactions in teleosts and
vertebrates with the Tol2 transposon element.
Our laboratory has used the Tol2 transposon system for
integration of reporter constructs in both X. laevis and X.
tropicalis [43]. We have demonstrated stable integration of
a  Tol2 transposon containing a minimal EF-1α promoter
driving expression of a GFP reporter into several X.
tropicalis founders [43] (Yergeau DA, Mead PE, unpub-
lished data). Mendelian ratios of GFP positive embryos were
achieved by the F2 generation through out-crossing of the
Tol2 GFP positive founders. This indicates that the initial
integration events occurred at early cleavage stages in the
founder line and resulted in chimerism in the germline of
the founder. We have found that Tol2 can integrate one to
multiple copies into the genome of the frog [43]. Polymerase
chain reaction based methodologies have been used to clone
the integration sites of the Tol2  transposons, and the
flanking sequences align precisely to X. tropicalis genome
sequence scaffolds. Sequence analysis of the Tol2 integration
sites also indicated that these were true transposition events,
because an eight base pair target site duplication flanking
the transposon could readily be identified.
Another transposon based system is piggyBac, originally
identified in moths [44]. Although it has not been tested to
date in Xenopus,  piggyBac has been shown to be more
efficient than SB and Tol2 in mammalian cell culture [45].
An amphibian specific transposase, Frog Prince, was
derived from an inactive transposon identified in the frog
Rana pipens [46] and has been shown to be able to integrate
a reporter construct into mammalian tissue culture cell
lines. Frog Prince has not been tested vigorously in vivo to
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frog. These two transposon systems may provide additional
tools for the generation of transgenic Xenopus for large scale
insertional mutagenesis screens.
Insertional mutagenesis screens (trap vectors)
Transposon systems have been used to generate transgenic
lines of frogs that express reporter genes, such as GFP,
under the control of tissue specific enhancer and promoter
elements. In addition to standard transgenesis, these
integration systems will provide excellent methodologies for
large-scale insertional mutagenesis screens in the frog.
Novel genetic loci can be identified using transposon vectors
that harbor gene or enhancer trap constructs that identify
genes close to the integration site. Enhancer trap vectors
contain minimal promoter elements that drive expression of
a reporter gene and can be used to identify gene regulatory
sequences in the regions that flank the integration site. The
activity of the endogenous enhancer element is determined
by tissue restricted expression of the reporter minigene.
Enhancer trap Tol2 transposon vectors have been used in
zebrafish to generate lines of fish with novel expression
patterns. The advantage of enhancer trap constructs is the
development of tissue restricted reporter lines, which are
invaluable for a variety of experimental approaches such as
fate mapping and transplantation studies. In addition, this
approach allows the potential to identify the endogenous
gene that is controlled by the trapped enhancer. However,
because enhancer elements can act over large distances, it is
unlikely that the enhancer trap integration event will be
mutagenic.
Gene trap vectors differ from enhancer traps in that they do
not contain a functional reporter mini-gene. The simplest
version of the gene trap is a construct that contains a splice
acceptor sequence upstream of the reporter sequence.
Integration of this vector into an actively transcribed locus
can result in generation of a fusion transcript that contains
the reporter gene and the endogenous gene. Several
laboratories have successfully developed transposon based
gene trap studies in the mouse [28] and zebrafish [32,33].
Splice acceptor gene trap vectors have also been used
successfully in frog. Bronchain and coworkers [47] used a
REMI strategy to stably integrate splice acceptor gene traps
into the frog genome and identified several novel genes.
Although splice acceptor gene trap vectors can function to
identify transcriptionally active genes, the efficiency of these
trap vectors is low because the integration event must occur
downstream of a functional splice donor site and the
resulting fusion must result in the reporter gene being in
frame with the upstream exons. Because the activity of the
reporter gene depends on the activity of the endogenous
gene, identification of the targeted loci may also be
complicated either by very low expression levels of the
trapped gene or by a narrow window of transcriptional
activity during development. If the endogenous gene is
expressed for a brief time during development, then the
expression of the reporter gene may potentially be missed.
Although the efficiency of this strategy is low, an advantage
of this system is that the integration event is likely to be
mutagenic. The intragenic integration and the generation of
a fusion transcript of the reporter with the endogenous gene
increase the likelihood that the insertion event will disrupt
the activity of the targeted gene. Another advantage of this
approach is that the integration site and the gene that is
targeted can easily be identified by using 5’-rapid
amplification of cDNA ends (RACE). This becomes an
advantage when sequence analysis of the DNA flanking the
transposon integration site provides no direct information
on the trapped gene. For example, if the integration event
occurs in a repeat region it may be impossible to determine
the locus that is targeted. Conversely, if the trap vector has
integrated into a gene dense region of the genome, then it
may be difficult to identify the actual gene that is trapped
because splicing may occur with exons that reside hundreds
of kilobases away.
A related strategy for gene trapping is the polyadenylation
(polyA) trap vector [48]. A polyA trap vector contains a
promoter that drives expression of a reporter gene but lacks
a functional polyadenylation signal in the 3’ untranslated
region. In the absence of a functional polyadenylation signal
the nascent transcript is unstable and does not result in
expression of the reporter protein. A splice donor site is
engineered at the 3’ end of the reporter gene such that
functional polyadenylation signals can be ‘trapped’ following
integration of the vector into a functional gene. The
advantage of this approach is that the expression level of the
reporter does not depend on the transcriptional activity of
the endogenous gene. All that is required for activity of the
polyA trap reporter is the sequestration of a function
polyadenylation signal. As such, both active and inactive
gene loci can be identified using this strategy. As with the
splice acceptor gene trap described above, the trapped loci
can be identified using 3’-RACE strategies. To increase the
mutagenic potential of the polyA trap vector, a gene
inactivation cassette can be cloned upstream of the reporter
mini-gene. A splice acceptor signal followed by a functional
3’ untranslated region sequence cloned at the 5’ end of the
reporter mini-gene will result in premature termination of
the endogenous gene [48].
Remobilization of transposons
A characteristic of DNA based transposon systems, such as
Tol2 and SB, is that a transposon integrated into the genome
is a substrate for remobilization by the transposase enzyme.
The high fecundity and long lifespan of X. tropicalis make
this model organism an excellent candidate for transposon
remobilization based insertional mutagenesis screens. A
transposon integrated into the host genome is stable but can
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transposase enzyme. The simplest strategy for re-expression
of the transposase is microinjection of mRNA encoding the
enzyme into fertilized eggs harvested from a transposon
transgenic animal. Founder lines of X. tropicalis females
containing the transposon can be stimulated to produce
large numbers of eggs and, once fertilized, the one cell
zygotes can then be injected with synthetic mRNA encoding
the transposase for remobilization in the offspring.
This approach has successfully been used in zebrafish to
remobilize a Tol2 enhance trap transposon and resulted in
multiple novel expression patterns in the injected progeny
[39,40]. The approach is technically feasible in the frog, and
large numbers of eggs for microinjection can be collected
from a single X. tropicalis female. However, it is time
consuming and labor intensive. Ideally, the microinjection
should be completed before the first cell division of the
embryo.  X. tropicalis embryos develop quickly, thus
decreasing the time available to inject prior to the first cell
division. Remobilization at early cleavage stages with
resulting chimeric embryos and out-crossing the progeny
will be required to isolate individual remobilized transposon
integration events. Nonetheless, simple microinjection of the
transposase provides a starting point for transposon
remobilization strategies in the frog.
The potential problems with the microinjection approach
can be resolved by using an in vivo remobilization strategy.
Expression of the transposase in vivo can be achieved by
generating transgenic lines that express enzyme under the
control of specific promoter and enhancer elements. Trans-
genes that direct expression of the transposase in the
germline of the frog can be used to achieve remobilization in
double transgenic animals that carry both the transposase
and the transposon substrate. Expression of the transposase
in the developing gametes results in mobilization of the
transposon substrate. If this strategy is performed in the
male germline, potentially millions of sperm with novel
reintegration events can be produced. This strategy has been
used extensively in the mouse, in which double transgenic
‘seed’ males are out-crossed to wild-type females and novel
reintegration events are scored in the progeny [31,49,50].
The frog is an ideal organism in which to apply this in vivo
transposon remobilization approach. First, the clutch size of
X. tropicalis is very large, and an out-cross of a double
transgenic seed frog with a wild-type female can yield up to
3,000 offspring. The double transgenic male frogs can be
out-crossed at least once per week, resulting in the potential
to generate vast numbers of offspring to score for novel
integration events. Second, the lifespan of the frog is long
and an individual double transgenic seed frog will survive
and produce offspring for more than a decade. Third,
because oogenesis occurs throughout the lifespan of the
female frog, germline remobilization in the female is also
feasible in the frog. Maintenance of maternal stores of the
transposase mRNA in the developing oocyte, however, may
result in continual remobilization events after fertilization
and may result in chimeric embryos. For this reason,
targeting expression of the transposase in the male germline
may be the preferred strategy for in vivo remobilization in
the frog. Finally, because the remobilization events have
occurred in the gametes before fertilization, the resulting
embryos will not be chimeric and will thus allow analysis of
the novel integration events in the progeny, and time
consuming out-crossing strategies will not be required.
Conclusion
Insertional mutagenesis strategies in the frog using DNA
based transposon systems will provide a mechanism for
identifying developmentally regulated genes and will
provide important reagents for the Xenopus community.
Gene and enhancer trap transgenic animals with tissue
specific expression patterns can be used in a variety of cell
and tissue transplantation studies in the frog and will also
provide tools for detailed fate mapping studies. Cells labeled
with fluorescent reporter genes can be isolated using
fluorescence activated cell sorting and used in combination
with gene expression microarrays to identify tissue specific
genes throughout early development.
The frog has been an important model for uncovering
fundamental developmental pathways. The recent push to
bring modern molecular techniques to the frog will allow the
power of modern molecular genetics to be applied to this
well established developmental model system. DNA based
transposon systems provide important advantages for
integration of novel genetic elements for both transgenesis
and insertional mutagenesis strategies. The high cargo
capacity of transposon systems such as Tol2 allow large and
complex transgenic constructs to be inserted into the frog
genome. Multifunction gene and enhancer trap vectors can
be developed that will increase the utility of the trapped loci.
For example, gene and enhancer trap vectors that direct
expression of Gal4-upstream activator sequence (UAS)
binary systems will provide useful tools for manipulating the
targeted cells (for review [51]). This binary system has been
used extensively in Drosophila and successfully applied in
REMI mediated transgenic Xenopus  [52]. A founder frog
with a specific transposon integration event harboring a
GAL4-UAS binary reporter transposon can be interbred with
other transgenic lines that carry functional proteins under
the control of UAS elements. In this way, specific constructs
can be expressed in the targeted cells during embryonic
development. Examples of potentially useful proteins to
express in this binary system include other fluorescent
reporters (such as red fluorescent protein [RFP] or yellow
fluorescent protein [YFP] for cell labeling and lineage
tracing), proteins that target the cell for cell death (such as
enzymes that convert prodrugs to cytotoxic compounds for
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from apoptotic death (such as Bcl2 to study the consequence
of maintaining specific cell types that are normally fated to
undergo programmed cell death).
The study of amphibian embryos has provided important
insight into the mechanisms of vertebrate development.
Combining modern molecular genetics with the simplicity of
embryonic manipulations in the frog will make this already
valuable system a more powerful model for elucidating
vertebrate development at the molecular level.
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